Results

Total Results: 921 records

Showing results for "morphine".

361. Luer Connector Misconnections: Under-Recognized but Potentially Dangerous Events. | PSNet
     psnet.ahrq.gov/issue/luer-connector-misconnections-under-recognized-potentially-dangerous-events
     November 19, 2008 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

362. Kadcyla (ado-trastuzumab emtansine): drug safety communication—potential medication errors resulting from name confusion. | PSNet
     psnet.ahrq.gov/issue/kadcyla-ado-trastuzumab-emtansine-drug-safety-communication-potential-medication-errors
     October 09, 2013 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

363. Strategic Plan for Preventing and Mitigating Drug Shortages. | PSNet
     psnet.ahrq.gov/issue/strategic-plan-preventing-and-mitigating-drug-shortages
     October 09, 2013 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

364. FDA Guidance Document: Hospital Bed System Dimensional and Assessment Guidance to Reduce Entrapment. | PSNet
     psnet.ahrq.gov/issue/fda-guidance-document-hospital-bed-system-dimensional-and-assessment-guidance-reduce
     March 22, 2006 - August 2, 2006 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

365. Relenza (zanamivir) inhalation powder. | PSNet
     psnet.ahrq.gov/issue/relenza-zanamivir-inhalation-powder
     October 21, 2009 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

366. An Introduction to the Improved FDA Prescription Drug Labeling. | PSNet
     psnet.ahrq.gov/issue/introduction-improved-fda-prescription-drug-labeling
     July 26, 2006 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

367. Interference between CT and Electronic Medical Devices. | PSNet
     psnet.ahrq.gov/issue/interference-between-ct-and-electronic-medical-devices
     March 03, 2010 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

368. Bar Code Label Requirements for Blood and Blood Components. | PSNet
     psnet.ahrq.gov/issue/bar-code-label-requirements-blood-and-blood-components
     May 03, 2006 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

369. MedWatch E-list. | PSNet
     psnet.ahrq.gov/issue/medwatch-e-list
     September 29, 2010 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

370. Important change to heparin container labels to clearly state the total drug strength. | PSNet
     psnet.ahrq.gov/issue/important-change-heparin-container-labels-clearly-state-total-drug-strength
     May 30, 2012 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

371. Benzocaine sprays marketed under different names, including Hurricaine, Topex, and Cetacaine. | PSNet
     psnet.ahrq.gov/issue/benzocaine-sprays-marketed-under-different-names-including-hurricaine-topex-and-cetacaine
     May 03, 2006 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

372. Promethazine HCl (marketed as Phenergan) Information. | PSNet
     psnet.ahrq.gov/issue/promethazine-hcl-marketed-phenergan-information
     February 22, 2006 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

373. New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients. | PSNet
     psnet.ahrq.gov/issue/new-dosing-recommendations-prevent-potential-valcyte-valganciclovir-overdose-pediatric
     August 11, 2010 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

374. Making Medical Devices Safer at Home. | PSNet
     psnet.ahrq.gov/issue/making-medical-devices-safer-home
     July 31, 2013 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

375. Safety Problems With Your Child's Medical Device? | PSNet
     psnet.ahrq.gov/issue/safety-problems-your-childs-medical-device
     January 09, 2013 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

376. FDA alerts health care professionals to the temporary absence of warning statement on the vial caps of two neuromuscular blocking agents. | PSNet
     psnet.ahrq.gov/issue/fda-alerts-health-care-professionals-temporary-absence-warning-statement-vial-caps-two
     June 22, 2011 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

377. Serious adverse events from accidental ingestion by children of over-the-counter eye drops and nasal sprays. | PSNet
     psnet.ahrq.gov/issue/serious-adverse-events-accidental-ingestion-children-over-counter-eye-drops-and-nasal-sprays
     December 19, 2012 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

378. Hospira Carpuject pre-filled cartridges—drug alert: products may contain more than the intended fill volume. | PSNet
     psnet.ahrq.gov/issue/hospira-carpuject-pre-filled-cartridges-drug-alert-products-may-contain-more-intended-fill
     December 19, 2012 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

379. Serious medication errors from intravenous administration of nimodipine oral capsules. | PSNet
     psnet.ahrq.gov/issue/serious-medication-errors-intravenous-administration-nimodipine-oral-capsules
     September 29, 2010 - February 16, 2011 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication

380. FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. | PSNet
     psnet.ahrq.gov/issue/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and
     January 25, 2017 - February 3, 2021 Morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL): medication